![Andrew Guggenhime](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Guggenhime
Director of Finance/CFO at
VAXCYTE, INC.
Net worth: 9 M $ as of 31/05/2026
Profile
Mr. Andrew L.
Guggenhime is a Chairman at Caribou Biosciences, Inc. and a President & Chief Financial Officer at Vaxcyte, Inc. Mr. Guggenhime was previously employed as an Independent Director by Metacrine, Inc., a Chief Financial Officer by Dermira, Inc., a Chief Financial Officer by Calistoga Pharmaceuticals, Inc., a Chief Financial Officer & Senior Vice President by Abbott Biotherapeutics Corp., a Chief Financial Officer & Senior Vice President by PDL BioPharma, Inc., a Chief Financial Officer & Senior Vice President by Neoforma, Inc., a Vice President by Merrill Lynch & Co., Inc., and an Assistant VP-Real Estate Capital Markets Group by Wells Fargo & Co. He also served on the board at CardioDx, Inc. He received his undergraduate degree from Middlebury College and an MBA from Kellogg School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VAXCYTE, INC. 0.12% | 18/06/2026 | 166,245 ( 0.12% ) | 9 M $ | 31/05/2026 |
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Andrew Guggenhime active positions
| Companies | Position | Start |
|---|---|---|
| VAXCYTE, INC. | Director of Finance/CFO | 01/05/2020 |
| CARIBOU BIOSCIENCES, INC. | Chairman | 01/07/2021 |
Former positions of Andrew Guggenhime
| Companies | Position | End |
|---|---|---|
| METACRINE, INC. | Director/Board Member | 23/03/2023 |
| DERMIRA, INC. | Director of Finance/CFO | 01/05/2020 |
| CARDIODX INC | Director of Finance/CFO | 28/04/2014 |
Calistoga Pharmaceuticals, Inc.
 Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Director of Finance/CFO | 01/04/2011 |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Director of Finance/CFO | 01/06/2010 |
Training of Andrew Guggenhime
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Wells Fargo & Co.
 Wells Fargo & Co. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer, commercial, corporate, investment banking and wealth management services | Finance |
Neoforma, Inc.
 Neoforma, Inc. Medical DistributorsDistribution Services Provides e-commerce services to healthcare industry | Distribution Services |
CardioDx, Inc.
 CardioDx, Inc. Medical/Nursing ServicesHealth Services Operates as a cardiovascular genomic diagnostics company | Health Services |
Calistoga Pharmaceuticals, Inc.
Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
Middlebury College
 Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
Merrill Lynch & Co., Inc.
 Merrill Lynch & Co., Inc. Investment ManagersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metacrine, Inc.
 Metacrine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
- Stock Market
- Insiders
- Andrew Guggenhime
